Year: All Releases2018201720162015201420132012 March 28, 2018 Mersana Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Provides Business Updates PDF Version March 21, 2018 Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Full Year 2017 Financial Results and Business Updates PDF Version March 19, 2018 Mersana Strengthens Board of Directors Leadership with Appointment of Willard H. Dere, M.D., Professor at the University of Utah and Retired Chief Medical Officer of Amgen PDF Version March 12, 2018 Mersana Appoints David A. Spellman as Chief Financial Officer PDF Version February 7, 2018 Mersana Therapeutics to Present at Upcoming Investor Conferences PDF Version January 8, 2018 Mersana Therapeutics Outlines 2017 Milestones and 2018 Goals PDF Version December 20, 2017 Mersana Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference PDF Version December 15, 2017 Mersana Therapeutics Added to NASDAQ Biotechnology Index PDF Version December 12, 2017 Mersana Announces First Patient Dosed with XMT-1536 in Phase 1 Study in Patients with NaPi2b-Expressing Tumors PDF Version 169.9 KB November 9, 2017 Mersana Announces Third Quarter 2017 Financial Results and Provides Business Updates PDF Version 357 KB Pagination First page First Previous page Previous … Page 2 Current page 3 Page 4 Page 5 … Next page Next Last page Last
